US Patent 11413351 CNP prodrugs with carrier attachment at the ring moiety
Patent 11413351 was granted and assigned to Ascendis Pharma on August, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 Apr, 2023
Golden AI
Edits on 1 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114133510
Date of Patent
August 16, 2022
0Patent Application Number
160670950
Date Filed
January 5, 2017
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114133510
Date of Patent
August 16, 2022
0Patent Application Number
160670950
Date Filed
January 5, 2017
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 17 Aug, 2022
Golden AI
Edits made to:
Infobox (+14 properties)
Article (+319 characters)
US Patent 11413351 CNP prodrugs with carrier attachment at the ring moiety
Article
The present invention relates to CNP prodrugs in which the carrier is covalently and reversibly attached to the ring moiety of a CNP moiety, to pharmaceutical compositions comprising such CNP prodrugs, to their uses and to methods of treating diseases that can be treated with the CNP prodrugs of the present invention.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11413351
Date of Patent
August 16, 2022
Patent Application Number
16067095
Date Filed
January 5, 2017
Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11413351 CNP prodrugs with carrier attachment at the ring moiety
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
